View in EDS HTML Full Text PDF Full Text

Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.

Saved in:
Bibliographic Details
Title: Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.
Authors: Salgado, Mercedes1 (AUTHOR), de la Camara-Gómez, Juan2 (AUTHOR), García-Escobar, Ignacio3 (AUTHOR), Álvarez-Llosa, Renata-Carola1 (AUTHOR), González-Villarroel, Paula4 (AUTHOR), Garay, David Fernández5 (AUTHOR), Pàmpols-Felip, Montse6 (AUTHOR), Guillot-Morales, Mónica7 (AUTHOR), Pelegrín-Mateo, Francisco José8 (AUTHOR), Jimenez-Orozco, Encarnación9 (AUTHOR), Sastre, Javier10 (AUTHOR), de Castro, Eva Martínez11 (AUTHOR), Coma, Eva12 (AUTHOR), Bouzas, Lorena París13 (AUTHOR), Ferrer-Pérez, Ana Isabel14 (AUTHOR), Mompradé-Olivé, Elisabet15 (AUTHOR), Cousillas-Castiñeiras, Antia16 (AUTHOR), Covela-Rúa, Marta17 (AUTHOR), Rojas, Mariam18 (AUTHOR), Querol, Rosa19 (AUTHOR)
Source: BMC Cancer. 11/17/2025, Vol. 25 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-025-14620-z